The Pfizer Foundation is pleased to announce a competitive grant offering aimed at optimizing the care of patients with muscle-invasive bladder cancer (MIBC) across Canada. This initiative invites proposals that seek to enhance treatment strategies, improve patient outcomes, and address existing gaps in the current care continuum for individuals diagnosed with MIBC. Through this funding,
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: